Skip to main content

Clinical trials

Explore how we turn our research into reality.

As we discover and develop new medicines, we conduct clinical trials to determine whether they are safe and effective for our patients. Interested in learning more about or participating in one of our clinical trials? Visit AbbVie Clinical Trials, an informational resource for patients, caregivers and healthcare professionals.
 

About Clinical Trials

A critical component of developing medicines is clinical research. This involves conducting clinical trials in humans to evaluate the safety and efficacy of investigational medications. Sometimes these studies include healthy volunteers but most of the studies are conducted in patients with the diseases we are studying.

Local authorities, such as the European Medicines Agency (EMA), the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, the U.S. Food and Drug Administration (FDA), as well as those in many other countries, use the data gathered in these trials to determine whether or not to approve the medication for use in their countries. To ensure these studies are conducted to the highest standards of protection for individuals who participate in the studies, AbbVie strictly follows important rules governing clinical research. These include the World Medical Association’s (WMA) Declaration of Helsinki, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and all applicable local rules and regulatory requirements.

For more information, please visit AbbVie Clinical Trials.

Committed to Good Clinical Practice

Throughout the clinical trials process, patients remain our highest priority. Good Clinical Practice (GCP) is a global ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with global ethical standards and regulatory requirements. Compliance also assures the credibility of the clinical data. AbbVie is committed to ensuring Good Clinical Practice is strictly adhered to within all AbbVie-sponsored clinical trials.

Clinical Trial Diversity

We believe in the design of inclusive research programs that offer equitable access and enhanced trial experiences for both patient and physician.

We are committed to being both intentional and representative when it comes to the inclusion of diverse populations of investigator staff and patients in the disease areas we are studying.

Additional information

Clinical Trials Data & Information Sharing

There are important health benefits in making clinical trial data and information available to health care providers, researchers, patients and the general public. We are committed to sharing information regarding our clinical trials while respecting patient confidentiality and the rights of our scientists.

We register all clinical trials on publicly accessible clinical trial registries in the U.S. and in the EU. Regardless of outcomes, we disclose the results of our clinical trials on the U.S. Government’s publicly accessible clinical trial registry. Results from clinical trials are also often published in peer-reviewed scientific or medical journal and presented at professional scientific or medical meetings.

We recognize the benefits of sharing our clinical trial information with researchers. That’s why qualified researchers engaged in rigorous, independent scientific research can request access to our anonymized clinical trial data.

Learn more about data and information sharing.

Postmarketing Commitments

Postmarket Commitments (PMCs) and Postmarket Requirements (PMRs) are studies and clinical trials conducted by a sponsor after the Food and Drug Administration (FDA) has approved a drug or biological product. The studies/trials are designed to generate additional information about the product’s safety, efficacy, or appropriate use. PMCs are studies or trials a sponsor has agreed with FDA to conduct; they are not required by statute or regulation. PMRs are studies or trials that sponsors are required to conduct post-approval according to statute or regulation.

AbbVie is subject to PMCs and PMRs covering a range of studies/trials in various stages of development. Information about AbbVie’s postmarketing commitments and requirements is believed to be correct at the time that the information is posted, and is subject to change as progress is made in fulfilling the commitments.

Find U.S. PMRs/PMCs for AbbVie U.S. products.

Join our clinical trial site network

AbbVie partners with leading scientific and medical professionals around the world to conduct clinical trials. We value the significant contributions that our scientific and medical professional partners make to our scientific innovation. AbbVie is committed to establishing collaborative partnerships to continuously grow our clinical trial site network.

To become a clinical trial investigator / investigative site on an AbbVie trial, submit your interest here: investigator.inquiry@abbvie.com